Hospira Methotrexate Injection USP, 2.5 g/100 mL vial (without preservative)

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

methotrexate, Quantity: 25 mg/mL

Beschikbaar vanaf:

Hospira Australia Pty Ltd

INN (Algemene Internationale Benaming):

Methotrexate

farmaceutische vorm:

Injection, intravenous infusion

Samenstelling:

Excipient Ingredients: sodium hydroxide; water for injections; sodium chloride; hydrochloric acid

Toedieningsweg:

Intravenous, Intrathecal, Intramuscular, Intraarterial

Eenheden in pakket:

1 x 100 mL pack

klasse:

Medicine Listed (Export Only)

Prescription-type:

(S1) This Schedule is intentionally blank

therapeutische indicaties:

Methotrexate Injection USP belongs to a group of medicines known as anti-metabolites. It is used in high doses to treat certain types of cancers, including breast cancer, Non-Hodgkin's lymphoma and leukemia. At lower doses, it may be used to treat psoriasis and severe rheumatoid arthritis.

Product samenvatting:

Visual Identification: A clear, yellow solution free from visible particulates; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store between 15-25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisatie-status:

Licence status A

Autorisatie datum:

2007-05-16